Biotech · Private company
Accelovance
Track this companyFree. Adds Accelovance to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials7
- Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer PatientsPHASE1 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT03120832 · fetched Nov 12, 2026
- Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne VulgarisPHASE2 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02661958 · fetched Nov 12, 2026
- A Prospective Study to Compare the Clinical Outcomes, Pain and Patient Quality of Life for Hernia PatientsCOMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02715622 · fetched Nov 12, 2026
- Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)PHASE2 · COMPLETED · started Apr 1, 2015ClinicalTrials.gov NCT02432846 · fetched Nov 12, 2026
- A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice InfestationPHASE3 · COMPLETED · started Feb 1, 2014ClinicalTrials.gov NCT02060903 · fetched Nov 12, 2026
- Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice InfestationPHASE3 · COMPLETED · started Feb 1, 2014ClinicalTrials.gov NCT02062060 · fetched Nov 12, 2026
- Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir LotionPHASE1 · COMPLETED · started Jan 1, 2014ClinicalTrials.gov NCT02062073 · fetched Nov 12, 2026